Literature DB >> 4816891

Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions.

W G Blackard, N C Nelson, S S Andrews.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4816891     DOI: 10.2337/diab.23.3.199

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  32 in total

1.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.

Authors:  A Basu; A Alzaid; S Dinneen; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

3.  Acute effects of distal pancreatectomy on portal and peripheral blood insulin concentrations in patients undergoing total gastrectomy.

Authors:  J Hayakawa; A Tsuburaya; H Motohashi; M Sairenji; O Kobayashi; K Suzuki; Y Usuda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  The role of the liver in glucagon metabolism.

Authors:  J B Jaspan; A H Huen; C G Morley; A R Moossa; A H Rubenstein
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

5.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Authors:  Tiffany D Farmer; Erin C Jenkins; Tracy P O'Brien; Gregory A McCoy; Allison E Havlik; Erik R Nass; Wendell E Nicholson; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

6.  The metabolic response to norepinephrine in normal versus diabetic man.

Authors:  D S Schade; R P Eaton
Journal:  Diabetologia       Date:  1978-12       Impact factor: 10.122

7.  Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet.

Authors:  H N Ginsberg; A Jacobs; N A Le; J Sandler
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.

Authors:  I Lager; H von Schenck; U Smith
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

9.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

10.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.